http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022249230-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91bf46dc5eca544aaad640797f270f27
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-9517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0014
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2463
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24
filingDate 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c941fe7ab1351f6d0411aa26386a378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3154f6a774477d6b8268cd964b73c8b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705dbb68d46959084864254174a2df5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743651ebf278401bb9aa783e56666f50
publicationDate 2022-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022249230-A1
titleOfInvention Prosthetic heart valve and delivery systems and methods
abstract An expandable prosthetic valve for implantation within a native mitral valve may be provided. The prosthetic valve may include an expandable valve body having an atrial end, a ventricular end opposite the atrial end, and an intermediate portion extending between the atrial end and the ventricular end. The valve body may include a plurality of struts intersecting at junctions. The prosthetic valve may also include a plurality of tissue anchoring legs extending from junctions within the intermediate portion of the valve body. At least one of the tissue anchoring legs may have a cross-sectional area which is larger by at least 20% than a cross-sectional area of a strut extending between the at least one tissue anchoring leg and an adjacent tissue anchoring leg.
priorityDate 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453035991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980

Total number of triples: 35.